BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261103T110000
DTEND;TZID=America/New_York:20261103T123000
DTSTAMP:20261022T173113Z
CREATED:20261014T171720Z
LAST-MODIFIED:20261022T173113Z
UID:3695-1793703600-1793709000@lifescievents.com
SUMMARY:Annexon Virtual Investor Event: Vonaprument for the Treatment of Geographic Atrophy - Preparing for Phase 3 ARCHER II Results
DESCRIPTION:Join Annexon for a virtual investor event providing an overview of Annexon’s platform of targeted immunotherapies including vonaprument\, a neuroprotective C1q inhibitor with potential to be the first targeted vision-preserving therapy for GA. Company management will highlight the Phase 3 ARCHER II clinical trial design\, patient demographics and communication strategy for the anticipated 15-month and 24-month results beginning in Q4 2026. The Company will also highlight the recent strengthening of its Ophthalmology team. \nThe event will feature Roger Goldberg\, MD\, MBA (Bay Area Retina Associates and ARCHER II Clinical Investigator)\, who will join company management to discuss the unmet need and current treatment landscape for geographic atrophy (GA)\, the advanced form of dry\, age-related macular degeneration (AMD) of the retina. \nA live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/anf05ek/.
URL:https://lifescievents.com/event/anf05ek/
LOCATION:Virtual\, Virtual
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/10/Annexon-Banner.png
END:VEVENT
END:VCALENDAR